Delivery Order SPE2DB22D3004-SPE2DB25FQE52
Award Date
4/8/25
Potential Completion Date
4/9/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,608.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of Entecavir 0.5 mg tablets, a pharmaceutical product used in the treatment of...
This federal contract award, valued at $8,414.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $2,841.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Entecavir 0.5 mg tablets, a generic medication used to treat chronic hepatitis B. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,091.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. This contract award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,978.40 and a period of performance ending on November 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,918.82 fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of February 19, 2025 and does not involve any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.09 firm fixed-price delivery order contract is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has a completion date of June 14, 2023 and was awarded on June 13, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $6,335.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp. The contract is for the delivery of Entecavir 0.5 mg tablets, a pharmaceutical product used in the treatment of hepatitis B. The contract has a firm fixed-price pricing type and an ultimate completion date of June 5, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $2,652.64, is for the delivery of Entecavir 0.5 mg Tablets, a medication used to treat chronic hepatitis B. The contract is a firm fixed price delivery order that is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Entecavir 0.5mg tablets. The contract, valued at $7,808.22, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 18, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...